Mutations in circulating tumor DNA predict primary resistance to systemic therapies in patients with advanced hepatocellular carcinoma

Johann von Felden; Amanda J. Craig; Ismaïl Labgaa; Teresa García‐Lezana; Delia D’Avola; Amon Asgharpour; Douglas T. Dieterich; Antoinette Bonaccorso; Miguel Torres‐Martín; Daniela Sia; Max W. Sung; Parissa Tabrizian; Myron Schwartz; Josep M. Llovet; Augusto Villanueva

doi:10.1016/s0168-8278(20)32229-7

Related publications

Article2020

Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma

Johann von Felden, Amanda J. Craig, Teresa García‐Lezana, Ismaïl Labgaa, Philipp K. Haber, Delia D’Avola, Amon Asgharpour, Douglas T. Dieterich, Antoinette Bonaccorso, Miguel Torres‐Martín, Daniela Sia, Max W. Sung, Parissa Tabrizian, Myron Schwartz, Josep M. Llovet, Augusto Villanueva

Oncogene

Article2022

Molecular pathogenesis and systemic therapies for hepatocellular carcinoma

Josep M. Llovet, Roser Pinyol, Robin Kate Kelley, Anthony B. El-Khoueiry, Helen L. Reeves, Xin Wei Wang, Gregory J. Gores, Augusto Villanueva

Nature Cancer

Article2010

227 CHANGES IN TUMOR BLOOD VOLUME AND PERFUSION ASSESSED PERFUSION COMPUTED TOMOGRAPHY PREDICT THE TIMING OF TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB

María Reig, Jordi Rimola, Alejandro Forner, Carlos Rodríguez de Lope, Silvia Tremosini, Carmen Ayuso, Josep M. Llovet, Jordi Bruix

Journal of Hepatology

Article2025

PD-L1 expressing circulating tumor cells to predict survival in patients with advanced hepatocellular carcinoma treated with immunotherapy

Kaloyan Radushev, Michael Karin, Daniel Rössler, Elif Öcal, Katrin Böttcher, Clint Gray, Julia Schneider, Stefan Enßle, Moritz Wildgruber, Max Seidensticker, Ignazio Piseddu, Andreas Geier, Julia Mayerle, Jens Ricke, Enrico N. De Toni, Ursula Ehmer, Florian P. Reiter, Najib Ben Khaled, Marianna Alunni‐Fabbroni

Article2015

P0221 : Acquired resistance to sorafenib in hepatocellular carcinoma is mediated by tumor initiating cells (cancer stem cells)

Victoria Tovar, Helena Cornellà, A. Moeni, Samuel J. Vidal, Yujin Hoshida, Daniela Sia, Judit Peix, Clara Alsinet, I.M. Quetglas, Manel Solé, Josep Domingo-Domènech, Augusto Villanueva, Josep M. Llovet